Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study

Completed · Not applicable

Conditions studied: End Stage Renal Failure on Dialysis

In brief

The purpose of the investigation is to confirm the safety and performance of the Argyle™ Safety Fistula Cannula with Anti-reflux Valve for hemodialysis treatment.

Key facts

Study ID

NCT05927532

Run by

Mozarc Medical US LLC

People needed

40

Starts

2024-03-10

Expected to finish

2024-12-15

Last updated by the study team

2026-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject who is aged 18 years or older who signed informed consent
• Subject is undergoing in-center hemodialysis
• Subject has an arteriovenous fistulae (AVF) fistula that was determined to be mature by standard clinical definition

You may not qualify if…

• Subject is enrolled in another study that could confound the results of this study, without documented pre-approval
• Subject with an existing arteriovenous graft
• Subjects with known allergies to plastics
• Subjects who are unable to read or respond to the questionnaire about satisfaction

Where it is running

• DaVita Hartford — Hartford, Connecticut, United States
• DaVita Columbus — Columbus, Georgia, United States
• DaVita Norfolk — Norfolk, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.